Chief Innovation & IP Officer
Co-Founder & Chief Innovation and Intellectual Property Officer
Peter is a qualified patent attorney in the UK and Europe with over 10 years’ experience in the pharmaceutical industry and has always had a passion for pharmaceutical innovation. He graduated from the University of Oxford in 2003 with a first class degree in Chemistry, following which he trained and qualified as a UK and European patent attorney specializing in pharmaceuticals.
In 2008, he joined Teva Pharmaceutical, a generic drug company, to work directly with pharmaceutical formulation teams but left in 2011 to return to private practice with AmLaw 100 firm Mintz Levin, where he advised start-up and mid-cap innovative pharma firms on IP and legal matters.
Peter left Mintz Levin in 2015 to set up Small Pharma where he operated as CEO until July 2022. He has since taken on the role of Chief Innovation & Intellectual Property Officer (CIIPO) to return to his roots in innovation and the protection of it. In August 2022, Peter will be relocating to the United States in order to better position the business for the later stages of clinical development and establish Small Pharma’s footprint in the US.